NuCana

0 followers


ProTide technology to transform some of the most widely prescribed chemotherapy / cancer agents

Industries

Employees

11-50

Links


Org chart

Hugh Griffith
Founder, CEO & Board Member
Collapse
Jeffrey Bloss
Chief Medical Officer
Theresa Bruce
SVP, Clinical Operations
Gordon Kennovin
VP, CMC & Development
Stuart Grant
VP, Regulatory Affairs
Ian Webster
Interim Chief Financial Officer

Board & advisors

Andrew Kay
Non Executive Chairman
Martin Mellish
Non Executive Director
Cyrille Leperlier
Non Executive Director
Bali Muralidhar
Non Executive Director
Elliott Levy
Non Executive Director